Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AVGO
4. ALNY
5. CNS
6. EC
7. SPCX
8. APO
9. SRE
10. HDB

Go back to Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)
Pfizer Inc. (NYSE: PFE) Delayed: 28.40 +0.44 (1.57%)
Previous Close $27.96    52 Week High $37.39 
Open $27.85    52 Week Low $28.25 
Day High $28.42    P/E 17.21 
Day Low $27.64    EPS $1.65 
Volume 16,284,658